Glycobiology Market Accounting For US$ 1,670.3 Mn By 2024

The term ‘Glycobiology’ was first introduced by Rademacher et al., in 1988, incorporating a varied array of molecules, collectively termed as ‘glycoconjugates’. Glycobiology is a branch of ‘Glycosciences’. Glycoscience is interdisciplinary stream having two branches viz. glycochemistry and glycobiology, which require the involvement of researchers in various disciplines including but not limited to medical science, pharmaceutical science, microbiology, biochemistry, material science, and biotechnology.

Extensive research related to carbohydrate molecule in various fields such as marine science and food & beverages industry is expected to fuel growth of the global glycobiology market. The global market is expected to reach a value of US$ 1,670.3 Mn by 2024, registering a CAGR of 12.8% between 2016 and 2024, according to a new report by Persistence Market Research (PMR).

PMR’s report offers market forecast and analysis on the global glycobiology market, while segmenting the market on the basis of product-type, application, end-user, and region. The report segments the global glycobiology market into five key regions: North America, Latin America, Europe, Middle East and Africa (MEA), and Asia Pacific (APAC). According to PMR regional analysis, North America (including the U.S. and Canada) is the most lucrative market for glycobiology globally.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @

Key Findings of the Report:

  • To investigate the competitive landscape – product launches, expansions, collaborations and acquisitions in the market.
  • To analyze and research the global market landscape and growth outlook, which includes, revenue, production, consumption, historical and forecast.
  • To recognize important drivers, restraints, opportunities, and threats (DROT Analysis)(SWOT Analysis).
  • To tactically examine the growth pattern and contribution to the market of every segment.

This region is expected to account for highest market share over the forecast period (2016–2024) and is expected to exhibit a significantly high growth rate. Asia Pacific is expected to be the fastest growing market in the global glycobiology market owing to increasing awareness amongst researchers regarding the various benefits of research related to carbohydrate molecules and its association with novel drug development. APAC is estimated to account for around 19.1% revenue share in the global glycobiology market by the end of 2016.

MEA region is also expected to register significant growth over the forecast period owing to increasing R&D expenditure by pharmaceutical industries. This region is expected to register a CAGR of 11.0% over the forecast period.

On the basis of product type, PMR has segmented the glycobiology market into instruments, enzymes, consumables and reagent kits segments. Enzymes product type segment is expected to dominate the market through the forecast period and is anticipated to be the most lucrative segment. Enzyme product type segment accounted for 52.6% revenue share in 2015.

Due to high adoption rate of enzymes to conduct various research initiatives, this segment is expected to witness high incremental opportunity globally.

For Critical Insights On The Glycobiology Market, Request For Customization Here @

On the basis of application, PMR has segmented the glycobiology market into drug discovery and development, therapeutic application, diagnostic application, industrial application, and others segments. Drug discovery and development application segment is expected to dominate the market and is anticipated to be the most lucrative segment growing at a CAGR of 13.4% over the forecast period.

On the basis of end user, the glycobiology market has been segmented into biopharmaceutical companies, research laboratories, hospitals, diagnostic centers, contract research organization, biotechnology industry, academic institutes, and others. PMR estimates that biopharmaceutical companies end user segment is expected to account for highest revenue share in the global glycobiology market and is expected to witness fastest growth over the forecast period.

Factors such as increasing demand for novel drug development, especially for chronic diseases such as cancer and diabetes, is expected to boost revenue share contribution from the biopharmaceutical companies segment. Research laboratories segment is also expected to register a significant growth rate during the forecast period.

The report discusses several factors affecting the global glycobiology market such as increment in R&D expenditure, key strategies of participant companies, and regional trends.

For In-Depth Competitive Analysis, Buy Now @

Company Profiled

  • Merck KGaA
  • Bio-Techne Corporation
  • Bruker Corporation
  • Thermo Fisher Scientific, Inc.
  • Shimadzu Corporation
  • Plexera Bioscience LLC
  • New England Biolabs Inc.
  • Agilent Technologies, Inc.
  • ProZyme, Inc.
  • Others.

More About the Report –

Unprecedented access to a world of information has given rise to the empowered, albeit distrustful, consumer. So is the case with healthcare, where the patient has been rendered more informed and conscientious thanks to the extraordinary penetration of the Internet. The discerning patient now demands more affordable, sophisticated, transparent, and personalized healthcare services, creating the need for new models for care.

The advent of health information technology (HIT) components such as electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and vendor-neutral archives (VNA) has had just as transformational an impact on the overall healthcare sector as the concerns regarding security and privacy. Data theft, undue access to personal health records, and cyber-attacks are very real threats that the healthcare sector faces today.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

Molecular Diagnostics Market –

Molecular Diagnostics Market Segmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.

Next-Generation Sequencing Market –

Next Generation Sequencing Market Segmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.

Ophthalmology devises Market –

Ophthalmology devises Market Segmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.

Intravenous Iron Drugs Market –

Intravenous (IV) Iron Drugs Market Segmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., and Sanofi.

Syndromes Progressive Ataxia Weakness Disorders Market –

Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Market Segmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States +1-646-568-7751
E-mail id-